Outlook: The Neuroscience Issue
Already one of the world’s premier institutions in neuroscience research, WashU Medicine is deepening its investment. Read about our approach, areas of focus and latest advances in Outlook Winter 2023-24.
Miller receives Rainwater Prize for Brain Research (Links to an external site)
Honored for work developing new kind of therapy for neurodegenerative diseases
Podcast: Recognizing, caring for dementia patients in the emergency department (Links to an external site)
This episode of ‘Show Me the Science’ looks at steps being taken to make it easier for people with dementia to navigate emergency room visits
Patients with brain cancer may benefit from treatment to boost white blood cells (Links to an external site)
Blocking immune suppressor cells in mice with glioblastoma improved survival
Podcast: Brain-related issues can linger after patients recover from COVID-19 (Links to an external site)
This episode of ‘Show Me the Science’ discusses one of the most common problems associated with long COVID-19
WashU, Eisai form drug discovery collaboration (Links to an external site)
Focus is on therapies for Alzheimer’s, other neurodegenerative diseases
Exercise, mindfulness don’t appear to boost cognitive function in older adults (Links to an external site)
In healthy older adults, neither led to measurable improvements after 6 months, 18 months
Immunotherapy eliminates disease-causing cells in mice with MS-like disease (Links to an external site)
Successful cancer treatment approach extended to autoimmune disease
WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictive (Links to an external site)
Goal is to reduce dangerous side effects of potent opioid pain reliever
Diagnostic marker found for deadly brain disease marked by dementia, movement problems (Links to an external site)
Discovery could accelerate progress toward therapies for primary tauopathies
Is it Alzheimer’s? Families want to know, and blood tests may offer answers. (Links to an external site)
